Celine Pallaud
Overview
Explore the profile of Celine Pallaud including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
911
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramos P, Choi J, Campbell C, Wang Y, Pallaud C, Dickinson M, et al.
EJHaem
. 2023 Aug;
4(3):876-881.
PMID: 37601870
Eltrombopag has been previously shown to be effective in reversing azacitidine-mediated thrombocytopenia. This was further investigated in the SUPPORT trial, a phase III study assessing the efficacy/safety of eltrombopag plus...
2.
Okoye-Okafor U, Javarappa K, Tsallos D, Saad J, Yang D, Zhang C, et al.
J Exp Med
. 2022 Sep;
219(11).
PMID: 36053753
Thrombocytopenia, prevalent in the majority of patients with myeloid malignancies, such as myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML), is an independent adverse prognostic factor. Azacitidine (AZA), a mainstay...
3.
Jahn N, Jahn E, Saadati M, Bullinger L, Larson R, Ottone T, et al.
Leukemia
. 2022 Aug;
36(9):2218-2227.
PMID: 35922444
The aim of this study was to characterize the mutational landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the randomized CALGB 10603/RATIFY trial evaluating intensive chemotherapy plus...
4.
Rucker F, Du L, Luck T, Benner A, Krzykalla J, Gathmann I, et al.
Leukemia
. 2021 Jul;
36(1):90-99.
PMID: 34316017
In acute myeloid leukemia (AML) internal tandem duplications of the FLT3 gene (FLT3-ITD) are associated with poor prognosis. Retrospectively, we investigated the prognostic and predictive impact of FLT3-ITD insertion site...
5.
Tausch E, Beck P, Schlenk R, Jebaraj B, Dolnik A, Yosifov D, et al.
Haematologica
. 2020 Oct;
105(10):2440-2447.
PMID: 33054084
Next generation sequencing studies in Chronic lymphocytic leukemia (CLL) have revealed novel genetic variants that have been associated with disease characteristics and outcome. The aim of this study was to...
6.
Voso M, Larson R, Jones D, Marcucci G, Prior T, Krauter J, et al.
Blood Adv
. 2020 Oct;
4(19):4945-4954.
PMID: 33049054
The results from the RATIFY trial (ClinicalTrials.gov: NCT00651261; CALGB 10603) showed that midostaurin combined with standard chemotherapy significantly improved outcomes in patients with FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid...
7.
Bruck O, Dufva O, Hohtari H, Blom S, Turkki R, Ilander M, et al.
Blood Adv
. 2020 Jan;
4(2):274-286.
PMID: 31968078
The immunologic microenvironment in various solid tumors is aberrant and correlates with clinical survival. Here, we present a comprehensive analysis of the immune environment of acute myeloid leukemia (AML) bone...
8.
Dohner K, Thiede C, Jahn N, Panina E, Gambietz A, Larson R, et al.
Blood
. 2019 Dec;
135(5):371-380.
PMID: 31826241
Patients with acute myeloid leukemia (AML) harboring FLT3 internal tandem duplications (ITDs) have poor outcomes, in particular AML with a high (≥0.5) mutant/wild-type allelic ratio (AR). The 2017 European LeukemiaNet...
9.
Kao Y, Chen J, Narayanagari S, Todorova T, Aivalioti M, Ferreira M, et al.
Sci Transl Med
. 2018 Sep;
10(458).
PMID: 30209246
Eltrombopag (EP), a small-molecule thrombopoietin receptor (TPO-R) agonist and potent intracellular iron chelator, has shown remarkable efficacy in stimulating sustained multilineage hematopoiesis in patients with bone marrow failure syndromes, suggesting...
10.
Garcia-Guerrero E, Gogishvili T, Danhof S, Schreder M, Pallaud C, Perez-Simon J, et al.
Blood
. 2017 May;
129(25):3386-3388.
PMID: 28476749
No abstract available.